Virology Research Services Ltd. (VRS) and Advanced Virology Inc. have joined forces in a strategic partnership that combines VRS's specialized testing capabilities with Advanced Virology's engineered virus production. Together, they offer an integrated solution for customers working in virology R&D, product development, manufacturing, and QC testing worldwide.
Virology Research Services: Bridging the Gap Between Discovery and Application
Based in the United Kingdom, Virology Research Services Ltd. specializes in providing consultancy and experimental services tailored to the complexities of individual projects. Operating from state-of-the-art CL2 and CL3 laboratories, VRS supports customers pursuing antiviral, vaccine, therapeutic, and diagnostic development studies. VRS services encompass product testing, assay development, and comprehensive study follow-ups, all underpinned by a commitment to rigorous science and customized solutions for each project.
As a 100% virology-focused CRO, VRS brings unmatched expertise to every stage of research, from antiviral discovery to vaccine development. With a proven track record since 2017, the team’s agile, scientist-to-scientist communication and flexible, submission-ready protocols ensure rapid turnaround and high-quality, publication-ready data.
Advanced Virology: Precision-Engineered Virus Stocks
Headquartered in the United States, Advanced Virology Inc. is at the forefront of custom virus stock production and quality control. The company utilizes cutting-edge reverse genetics systems to provide high-fidelity virus stocks and derivative products, including wild-type strains, reporter-expressing variants, inactivated virus preparations, and custom mutants. Advanced Virology products are used in vaccine development, antiviral therapeutics research, and diagnostic applications to raise industry standards and accelerate project timelines.
A Synergistic Partnership: Enhancing Research and Product Development
The collaboration between VRS and Advanced Virology Inc. creates an end-to-end service for customers pursuing virology R&D projects:
Integrated Services: Customers can access both high-fidelity virus stocks and specialized experimental services, streamlining project workflows and reducing time to results.
Customized Solutions: The partnership enables the development of custom virus strains and tailored experimental protocols to meet specific R&D needs.
Accelerated Innovation: By combining expertise in virus production and experimental services, the partnership fosters rapid advancement in vaccine development, antiviral therapies, and diagnostic tools.
Quality Assurance: Combined expertise ensures both virus stocks and testing meet the highest industry standards throughout the entire research workflow.
A Shared Commitment to Advancing Virology
Virology Research Services views this partnership as a transformative collaboration that continues to accelerate R&D and product development by providing seamless access to high-quality viral materials and expert experimental support. The shared mission is to drive faster development of vaccines, antivirals, and diagnostics for the global research community.
“Advanced Virology closes a key gap in virology research by delivering genetically uniform, fully characterized viruses and mutants. This partnership gives VRS clients access not only to clean background strains but also to custom-designed mutants, providing crucial insights into how viral evolution affects their therapeutics and helping them stay one step ahead of the virus.” – Michela Mazzon, PhD, Director, Virology Research Services Ltd.
“The partnership between VRS and Advanced Virology streamlines virology research in a new, original way. By combining VRS’s specialized testing capabilities with Advanced Virology’s engineered virus production, we offer a complete, integrated solution for researchers. From initial screening to final validation, clients can now access all stages under one partnership, accelerating the journey from research to breakthrough.”
“We are proud to collaborate with a top-tier virology services company such as VRS. Together, we are enabling customers to execute R&D projects more efficiently and explore new research directions that were not previously feasible.” – Nishank Bhalla, PhD, Senior Scientist, Advanced Virology Inc.
Sample Projects:
• A customer developing a diagnostic test for a newly emerging virus strain can acquire a high-fidelity, non-lab-adapted virus stock from Advanced Virology Inc. and commission VRS to support assay development and validation.
• A customer testing antiviral compounds and therapeutics against circulating wild-type virus strains can order custom variants carrying the circulating mutants from Advanced Virology Inc. and commission compound testing from VRS at the same time.
Together, VRS and Advanced Virology are redefining what is possible in virology research. As the virology CRO and a leader in engineered virus production, their combined strength delivers end-to-end solutions that accelerate innovation and ensure scientific excellence from bench to breakthrough.
For more information on their combined offerings and how to collaborate, visit Virology Research Services and Advanced Virology Inc.